limestone has been researched along with Chronic Kidney Diseases in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (4.65) | 29.6817 |
| 2010's | 37 (86.05) | 24.3611 |
| 2020's | 4 (9.30) | 2.80 |
| Authors | Studies |
|---|---|
| Chariyavilaskul, P; Eiam-Ong, S; Katavetin, P; Leelahavanichkul, A; Phannajit, J; Praditpornsilpa, K; Puapatanakul, P; Sitticharoenchai, P; Sukkumme, W; Susantitaphong, P; Takkavatakarn, K | 1 |
| Bonilla-Ramírez, C; Hernández-Calderón, FJ; Herrera, MF; Pantoja-Millán, JP; Ponce de León-Ballesteros, G; Sierra-Salazar, M; Velázquez-Fernández, D | 1 |
| Akizawa, T; Fukagawa, M; Fukushima, M; Hirakata, H; Kagimura, T; Ogata, H | 1 |
| Andric, B; Barratt, J; Mariat, C; Reusch, M; Schömig, M; Tataradze, A; Valluri, U | 1 |
| Fujii, H; Goto, S; Kono, A; Kono, K; Nakai, K; Nishi, S; Nishii, T | 1 |
| Wang, S; Zhang, C; Zhang, X; Zhao, S | 1 |
| Barnea, Z; Biro, A; Cernes, R; Katzir, Z; Zandman-Goddard, G | 1 |
| Garg, AX; Habbous, S; Martin, J; Przech, S; Sarma, S | 1 |
| Brito, JB; Carminatti, M; Custodio, MR; de Albuquerque Suassuna, PG; de Castro, BBA; de Oliveira, IB; do Carmo, WB; Dominguez, WV; Jorgetti, V; Sanders-Pinheiro, H | 1 |
| Gao, Y; Li, Y; Lv, C; Wang, G; Wang, Z | 1 |
| Fujii, H; Goto, K; Goto, S; Kono, K; Nishi, S; Watanabe, K | 1 |
| Armas, LA; Heaney, RP; Lund, R; Zena, M | 1 |
| Bartko-Winters, S; Bernard, L; Di Iorio, B; Fenton, A; Hutchison, C; Thompson, M | 1 |
| Evenepoel, P; Wolf, M | 1 |
| Chatterley, T; Dorgan, M; Fitchett, D; Jamal, SA; Lok, CE; Mendelssohn, DC; Raggi, P; Tsuyuki, RT; Vandermeer, B | 1 |
| Bennett-Jones, D; Dasgupta, I; McVeigh, G; Shroff, R | 1 |
| Wada, K; Wada, Y | 1 |
| Bellasi, A; Di Iorio, B; Pota, A; Russo, D; Russo, L | 1 |
| Kong, XL; Li, WB; Wang, ZS; Wei, Y | 1 |
| Eräranta, A; Kööbi, P; Lakkisto, P; Moilanen, E; Mustonen, J; Niemelä, O; Pörsti, I; Tikkanen, I; Törmänen, S; Vehmas, TI | 1 |
| Bellasi, A; Cipriani, F; Di Iorio, B; Ruggeri, M; Russo, D | 1 |
| Sun, J; Wang, R; Yang, XW; Zhai, CJ | 1 |
| Kitazono, T; Noguchi, H; Ooboshi, H; Tatsumoto, N; Tokumoto, M; Tsuruya, K; Yamada, S | 1 |
| Imanishi, Y; Inaba, M; Ishimura, E; Nagayama, H; Okuno, S; Shoji, S; Yamada, S | 1 |
| Graves, A; Lambe, G; Malvathu, R; Thomas, HM | 1 |
| Ito, T; Iwashita, Y; Shigematsu, T | 1 |
| Drożdż, D; Drożdż, T; Kwinta, P; Miklaszewska, M; Pietrzyk, JA; Sztefko, K; Zachwieja, K; Łatka, M | 1 |
| Gutekunst, L | 1 |
| Bose, S; Finkelstein, E; Nguyen, HV | 1 |
| Rizk, R | 1 |
| Akizawa, T; Fukagawa, M; Hirakata, H; Kagimura, T; Kaneda, H; Ogata, H | 1 |
| Anderson, CA; Nguyen, HA; Rifkin, DE | 1 |
| Chang, YM; Chen, IL; Hsu, KS; Huang, YT; Jhen, RN; Kao, JL; Liou, HH; Liu, MC; Shiao, CC; Tsai, SC; Tung, NY; Yang, CL | 1 |
| Bernardino, M; Parmar, MS | 1 |
| Athapattu, BCL; Thalgaspitiya, TWLR; Vithanage, M; Yasaratne, ULS | 1 |
| Craig, JC; Elder, GJ; Navaneethan, SD; Palmer, SC; Strippoli, GF | 1 |
| Al-Ramahi, R | 1 |
| Blake, PG; Filler, G; Roach, E; Sharma, AP; Yang, L; Yasin, A | 1 |
| Akita, W; Asai, T; Iimori, S; Ishigami, J; Kuwahara, M; Kuyama, T; Mori, Y; Ohnishi, T; Okado, T; Sasaki, S; Shikuma, S; Tajima, M; Takada, S; Tsukamoto, Y | 1 |
| Chiyotanda, S; Fujimoto, S; Fukudome, K; Kitamura, K; Sato, Y; Toida, T; Yamada, K | 1 |
| Hill, KM; Martin, BR; McCabe, GP; Moe, SM; Peacock, M; Wastney, ME; Weaver, CM | 1 |
| Aljama, P; Almadén, Y; Martín-Malo, A; Ojeda, R; Rodríguez, M; Soriano, S | 1 |
| Davies, MR; Hruska, KA; Lund, RJ; Mathew, S | 1 |
9 review(s) available for limestone and Chronic Kidney Diseases
| Article | Year |
|---|---|
Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease.
Topics: Adult; Aged; Calcium Carbonate; Chelating Agents; Cost-Benefit Analysis; Female; Humans; Hyperphosphatemia; Lanthanum; Male; Middle Aged; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Sevelamer | 2018 |
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.
Topics: Acetates; Aged; Calcium Carbonate; Calcium Compounds; Cause of Death; Chelating Agents; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Phosphates; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic | 2013 |
Management of hyperphosphataemia in chronic kidney disease: summary of National Institute for Health and Clinical Excellence (NICE) guideline.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Chelating Agents; Chelation Therapy; Diet Therapy; Evidence-Based Medicine; Humans; Hyperphosphatemia; Nephrology; Practice Guidelines as Topic; Renal Dialysis; Renal Insufficiency, Chronic; United States | 2013 |
Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis.
Topics: Bone Density; Calcium; Calcium Carbonate; Chelating Agents; Humans; Hypercalcemia; Lanthanum; Parathyroid Hormone; Phosphorus; Radiography; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Vascular Calcification | 2015 |
Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormone.
Topics: Calcium Carbonate; Female; Humans; Lanthanum; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic | 2015 |
[Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)].
Topics: Bone and Bones; Bone Diseases, Metabolic; Calcimimetic Agents; Calcinosis; Calcium Carbonate; Cardiovascular Diseases; Cinacalcet; Ferric Compounds; Fractures, Bone; Humans; Minerals; Parathyroidectomy; Phosphates; Phosphorus, Dietary; Renal Insufficiency, Chronic; Risk Factors; Sevelamer | 2016 |
An Update on Phosphate Binders: A Dietitian's Perspective.
Topics: Aluminum Hydroxide; Calcium Carbonate; Diet; Dose-Response Relationship, Drug; Humans; Hyperphosphatemia; Lanthanum; Nutritionists; Phosphates; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic | 2016 |
Nutrition Interventions in Chronic Kidney Disease.
Topics: Body Weight; Calcium Carbonate; Cardiovascular Diseases; Chelating Agents; Diet; Diet, Mediterranean; Dyslipidemias; Exercise; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperglycemia; Lanthanum; Phosphorus, Dietary; Protein-Energy Malnutrition; Renal Insufficiency, Chronic; Sodium, Dietary; Water-Electrolyte Balance | 2016 |
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
Topics: Acetates; Biomarkers; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hypercalcemia; Hyperphosphatemia; Lanthanum; Parathyroid Hormone; Phosphates; Phosphorus; Polyamines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Research Design; Sevelamer | 2009 |
15 trial(s) available for limestone and Chronic Kidney Diseases
| Article | Year |
|---|---|
Protein-Bound Uremic Toxins Lowering Effect of Sevelamer in Pre-Dialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized Controlled Trial.
Topics: Calcium Carbonate; Chelating Agents; Cresols; Female; Humans; Hyperphosphatemia; Indican; Male; Middle Aged; Renal Insufficiency, Chronic; Sevelamer; Sulfuric Acid Esters; Uremic Toxins | 2021 |
Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
Topics: Aged; Calcium Carbonate; Cardiovascular Diseases; Female; Heart Disease Risk Factors; Hip Fractures; Humans; Hyperparathyroidism; Hyperphosphatemia; Incidence; Japan; Lanthanum; Male; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Survival Analysis; Vascular Calcification | 2021 |
Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES).
Topics: Anemia; Calcium Carbonate; Glycine; Hematinics; Hemoglobins; Humans; Isoquinolines; Magnesium; Renal Dialysis; Renal Insufficiency, Chronic | 2021 |
Effect of lanthanum carbonate on coronary artery calcification and bone mineral density in maintenance hemodialysis patients with diabetes complicated with adynamic bone disease: A prospective pilot study.
Topics: Administration, Oral; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Diseases; Calcinosis; Calcium Carbonate; Coronary Artery Disease; Diabetes Complications; Female; Fibroblast Growth Factor-23; Humans; Lanthanum; Male; Middle Aged; Pilot Projects; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome | 2017 |
Effects of oral activated charcoal on hyperphosphatemia and vascular calcification in Chinese patients with stage 3-4 chronic kidney disease.
Topics: Administration, Oral; Adult; Aged; Biomarkers; Calcium Carbonate; Charcoal; Chelating Agents; Female; Humans; Hyperphosphatemia; Lanthanum; Male; Middle Aged; Phosphates; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome; Vascular Calcification | 2019 |
Calcium absorption response to cholecalciferol supplementation in hemodialysis.
Topics: Aged; Calcium Carbonate; Calcium, Dietary; Cholecalciferol; Dietary Supplements; Female; Humans; Intestinal Absorption; Male; Middle Aged; Nebraska; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome; Vitamin D; Vitamins | 2013 |
Evaluation of aortic calcification with lanthanum carbonate vs. calcium-based phosphate binders in maintenance hemodialysis patients with type 2 diabetes mellitus: an open-label randomized controlled trial.
Topics: Aged; Aortic Diseases; Calcinosis; Calcium Carbonate; Chelating Agents; Diabetes Mellitus, Type 2; Disease Progression; Female; Humans; Lanthanum; Male; Middle Aged; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Tomography, X-Ray Computed | 2014 |
Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease.
Topics: Aged; Calcium Carbonate; Cause of Death; Chelating Agents; Coronary Vessels; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification | 2015 |
Effect of calcium carbonate combined with calcitonin on hypercalcemia in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Calcium; Calcium Carbonate; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Young Adult | 2014 |
Design and baseline characteristics of the LANDMARK study.
Topics: Aged; Biomarkers; Calcium Carbonate; Cardiovascular Diseases; Chelating Agents; Clinical Protocols; Disease-Free Survival; Female; Humans; Hyperphosphatemia; Japan; Lanthanum; Male; Middle Aged; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Research Design; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients.
Topics: Aged; Biomarkers; Calcium Carbonate; Chelating Agents; Down-Regulation; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Hepcidins; Humans; Lanthanum; Male; Middle Aged; Phosphates; Phosphorus, Dietary; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Taiwan; Time Factors; Treatment Outcome | 2017 |
Effects of sevelamer hydrochloride on mortality, lipid abnormality and arterial stiffness in hemodialyzed patients: a propensity-matched observational study.
Topics: Aged; Ankle Brachial Index; Calcium Carbonate; Chelating Agents; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lipid Metabolism; Male; Middle Aged; Polyamines; Pulse Wave Analysis; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Severity of Illness Index; Survival Rate; Vascular Stiffness | 2012 |
Effect of lanthanum carbonate vs. calcium carbonate on serum calcium in hemodialysis patients: a crossover study.
Topics: Acid Phosphatase; Aged; Alkaline Phosphatase; Analysis of Variance; Calcium; Calcium Carbonate; Chelating Agents; Chi-Square Distribution; Cross-Over Studies; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypercalcemia; Hyperphosphatemia; Isoenzymes; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Tartrate-Resistant Acid Phosphatase; Vitamin D | 2012 |
Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease.
Topics: Administration, Oral; Aged; Analysis of Variance; Biomarkers; Calcium; Calcium Carbonate; Chelating Agents; Cross-Over Studies; Feces; Female; Glomerular Filtration Rate; Humans; Indiana; Kidney; Kinetics; Least-Squares Analysis; Male; Middle Aged; Phosphorus; Renal Insufficiency, Chronic; Severity of Illness Index; Treatment Outcome | 2013 |
The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Calcium Carbonate; Chelating Agents; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphates; Renal Insufficiency, Chronic; Statistics, Nonparametric; Vitamin D | 2013 |
19 other study(ies) available for limestone and Chronic Kidney Diseases
| Article | Year |
|---|---|
Mid-Term and Long-Term Impact of Permanent Hypoparathyroidism After Total Thyroidectomy.
Topics: Abdominal Pain; Acute Coronary Syndrome; Adult; Aged; Arrhythmias, Cardiac; Calcium Carbonate; Depression; Diarrhea; Fatigue; Female; Glomerular Filtration Rate; Humans; Hypocalcemia; Hypoparathyroidism; Infections; Irritable Mood; Male; Middle Aged; Postoperative Complications; Renal Insufficiency, Chronic; Retrospective Studies; Thyroidectomy; Young Adult | 2020 |
Effects of Lanthanum Carbonate on Coronary Artery Calcification and Cardiac Abnormalities After Initiating Hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Calcium Carbonate; Chelating Agents; Coronary Vessels; Female; Fibroblast Growth Factor-23; Humans; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Vascular Calcification | 2018 |
Severe Hypocalcemia Following a Single Denosumab Injection.
Topics: Aged, 80 and over; Bone Density Conservation Agents; Calcium Carbonate; Denosumab; Female; Humans; Hydroxycholecalciferols; Hypocalcemia; Osteoporosis, Postmenopausal; RANK Ligand; Renal Insufficiency, Chronic; Treatment Outcome; Vitamin D Deficiency | 2017 |
Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
Topics: Animals; Calcium Carbonate; Chitosan; Iron; Male; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Uremia; Vascular Calcification | 2018 |
Effects of lanthanum carbonate on bone markers and bone mineral density in incident hemodialysis patients.
Topics: Aged; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Calcium; Calcium Carbonate; Female; Humans; Lanthanum; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Tartrate-Resistant Acid Phosphatase | 2019 |
Economic evaluation of sevelamer for the treatment of hyperphosphatemia in chronic kidney disease patients not on dialysis in the United Kingdom.
Topics: Calcium Carbonate; Chelating Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Female; Humans; Hyperphosphatemia; Male; Markov Chains; Middle Aged; Polyamines; Quality-Adjusted Life Years; Regression Analysis; Renal Insufficiency, Chronic; Sevelamer; United Kingdom | 2013 |
A balanced view of calcium and phosphate homeostasis in chronic kidney disease.
Topics: Calcium; Calcium Carbonate; Chelating Agents; Female; Humans; Kidney; Male; Phosphorus; Renal Insufficiency, Chronic | 2013 |
Phosphate binding reduces aortic angiotensin-converting enzyme and enhances nitric oxide bioactivity in experimental renal insufficiency.
Topics: Acetylcholine; Animals; Aorta; Aortic Diseases; Blood Pressure; Calcinosis; Calcium Carbonate; Endothelium; Mesenteric Arteries; Nephrectomy; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Norepinephrine; Oxidative Stress; Parathyroid Hormone; Peptidyl-Dipeptidase A; Phosphates; Rats; Renal Insufficiency, Chronic; Vasoconstriction; Vasodilation | 2014 |
Sevelamer is cost-saving vs. calcium carbonate in non-dialysis-dependent CKD patients in italy: a patient-level cost-effectiveness analysis of the INDEPENDENT study.
Topics: Aged; Calcium Carbonate; Cause of Death; Chelating Agents; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Hyperphosphatemia; Male; Middle Aged; Mortality; Polyamines; Renal Insufficiency, Chronic; Sevelamer; Time Factors; Treatment Outcome | 2014 |
Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
Topics: Adenine; Animal Feed; Animals; Calcinosis; Calcium Carbonate; Cellular Senescence; Disease Models, Animal; Disease Progression; Fibrosis; Immunohistochemistry; Inflammation; Kidney; Kidney Failure, Chronic; Lanthanum; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Phosphates; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Signal Transduction; Uremia; Vascular Calcification | 2015 |
Hypocalcaemic tetany occurring post a single denosumab dose in a patient with stage 4 chronic kidney disease, followed by calcium- and calcitriol-induced hypercalcaemia.
Topics: Aged, 80 and over; Bone Density Conservation Agents; Calcitriol; Calcium Carbonate; Cholecalciferol; Denosumab; Female; Fractures, Bone; Humans; Hypercalcemia; Hypocalcemia; Medication Errors; Renal Insufficiency, Chronic; Tetany | 2015 |
[Do we successfully treat anemia and calcium-phosphate disorders in children with chronic kidney disease at the beginning of the twenty-first century?].
Topics: Adolescent; Anemia; Calcium Carbonate; Child; Disease Progression; Erythropoietin; Female; Humans; Hydroxycholecalciferols; Hyperphosphatemia; Hypocalcemia; Male; Parathyroid Hormone; Renal Insufficiency, Chronic; Treatment Outcome | 2015 |
Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Calcium Carbonate; Chelating Agents; Cost-Benefit Analysis; Female; Humans; Hyperphosphatemia; Male; Markov Chains; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Singapore; Treatment Outcome; Young Adult | 2016 |
Cost-effectiveness of phosphate binders among patients with chronic kidney disease not yet on dialysis: a long way to go.
Topics: Calcium Carbonate; Chelating Agents; Cost-Benefit Analysis; Humans; Hyperphosphatemia; Renal Insufficiency, Chronic; Sevelamer | 2016 |
Oxalate nephropathy from cashew nut intake.
Topics: Anacardium; Calcium Carbonate; Chelating Agents; Female; Humans; Hyperoxaluria; Middle Aged; Nuts; Oxalates; Renal Insufficiency, Chronic | 2017 |
Biochar-based constructed wetlands to treat reverse osmosis rejected concentrates in chronic kidney disease endemic areas in Sri Lanka.
Topics: Alkalies; Calcium Carbonate; Charcoal; Endemic Diseases; Environmental Restoration and Remediation; Fluorides; Humans; Osmosis; Pilot Projects; Renal Insufficiency, Chronic; Sri Lanka; Water Purification; Water Quality; Water Supply; Wetlands | 2017 |
Medication prescribing patterns among chronic kidney disease patients in a hospital in Malaysia.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Calcium Carbonate; Chi-Square Distribution; Dietary Supplements; Drug Prescriptions; Female; Ferrous Compounds; Folic Acid; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Malaysia; Male; Metoprolol; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Renal Insufficiency, Chronic; Vitamin B Complex | 2012 |
High prevalence of elevated lead levels in pediatric dialysis patients.
Topics: Adolescent; Antacids; Calcium Carbonate; Child; Child, Preschool; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Infant; Lead; Male; Mass Spectrometry; Prevalence; Renal Dialysis; Renal Insufficiency, Chronic; Young Adult | 2012 |
Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives.
Topics: Animals; Aorta, Thoracic; Bone Diseases; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Calcinosis; Calcium; Calcium Carbonate; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Dietary Fats; Disease Progression; Female; Hyperparathyroidism; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Osteoblasts; Osteogenesis; Phosphates; Renal Insufficiency, Chronic; Transforming Growth Factor beta | 2005 |